Langerhans Cell Histiocytosis

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Overview

Langerhans cell histiocytosis (LCH) is a rare cancer that begins in LCH cells, a type of dendritic cell (white blood cell ). LCH cells can grow in many different parts of the body, where they can damage tissue or form lesions.

LCH may occur at any age but is most common in young children. In infants up to one year of age, LCH may go away without treatment. Treatment of LCH in children is different from treatment of LCH in adults.

LCH in the skin, bones, lymph nodes, or pituitary gland usually gets better with treatment and is called "low-risk." LCH in the spleen, liver, or bone marrow is harder to treat and is called "high-risk."

Image of a dendritic cell.  Langerhans cell histiocytosis is cancer of dendritic cells. This image was created with an electron microscope.

Treatment

PDQ Treatment Information

Causes & Prevention

NCI does not have PDQ evidence-based information about prevention of langerhans cell histiocytosis.
More information

Screening

NCI does not have PDQ evidence-based information about screening for langerhans cell histiocytosis.
More information